Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Is Corbus Pharmaceuticals (CRBP) Stock Outpacing Its Medical Peers This Year?
11:20am, Friday, 01'st Dec 2023
Here is how Corbus Pharmaceuticals (CRBP) and CVRx (CVRX) have performed compared to their sector so far this year.
Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting
09:05am, Wednesday, 27'th Sep 2023
NORWOOD, Mass. , Sept. 27, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an abstract highlig
Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
08:00am, Thursday, 02'nd Mar 2023
NORWOOD, Mass. , March 2, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that Yuval Cohen, Ph.D.
Buying Penny Stocks in December? 3 Top Tips to Profit
06:00am, Thursday, 01'st Dec 2022
Use these tips to buy penny stocks in December The post Buying Penny Stocks in December? 3 Top Tips to Profit appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
10 Top Penny Stocks To Buy For Uner $1 Right Now
01:27pm, Friday, 21'st Oct 2022
Penny stocks to watch under $1 right now. The post 10 Top Penny Stocks To Buy For Uner $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
How to Find Popular Penny Stocks Right Now
06:00am, Friday, 21'st Oct 2022
Use these tips for finding popular penny stocks to buy right now The post How to Find Popular Penny Stocks Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
Good Penny Stocks To Buy Now? 7 Under $1 To Watch This Week
02:28pm, Thursday, 20'th Oct 2022
Penny stocks to watch under $1 right now. The post Good Penny Stocks To Buy Now?
NORWOOD, Mass. , Oct. 14, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today announced a poster presentation at the SI
Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates
01:25pm, Tuesday, 10'th May 2022 Zacks Investment Research
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of 11.11% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Corbus Pharmaceuticals (CRBP) Reports Q1 Loss, Lags Revenue Estimates
10:32am, Tuesday, 10'th May 2022
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of 11.11% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Corcept's (CORT) Q1 Earnings & Revenues Fall Shy of Estimates
03:11pm, Friday, 06'th May 2022 Zacks Investment Research
Corcept's (CORT) earnings as well as revenues miss estimates in the first quarter of 2022.
Pacira's (PCRX) Q1 Earnings Miss Estimates, Revenues Rise Y/Y
03:26pm, Thursday, 05'th May 2022 Zacks Investment Research
Pacira's (PCRX) earnings fall shy of estimates in the first quarter of 2022 while revenues beat the same.
Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates
03:07pm, Thursday, 05'th May 2022 Zacks Investment Research
Zoetis' (ZTS) earnings and revenues trump estimates in the first quarter of 2022.
AlloVir (ALVR) Up on Third RMAT Status From FDA for Posoleucel
03:35pm, Thursday, 21'st Apr 2022 Zacks Investment Research
The FDA bestows a third Regenerative Medicine Advanced Therapy designation to AlloVir's (ALVR) lead candidate, posoleucel, for preventing life-threatening infections from six viruses. Shares rise.
Citius (CTXR) Posts Top-Line Data From Pivotal Lymphoma Study
01:57pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Citius (CTXR) releases encouraging top-line data from the phase III study on I/ONTAK for the treatment of persistent or recurrent cutaneous T-cell lymphoma.
